Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on medication abortion.

Margaret W Beal1

  • 1Yale University School of Nursing, 100 Church Street South, PO Box 9740, New Haven, CT 06536-0740, USA. margaret.beal@yale.edu

Journal of Midwifery & Women'S Health
|January 9, 2007
PubMed
Summary

Medication abortion using mifepristone is widely adopted in the US, offering a safe alternative to surgical procedures. This review examines its safety, efficacy, and clinical implications post-FDA approval.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updates to the US Food and Drug Administration Regulations for Mifepristone: Implications for Clinical Practice and Access to Abortion.

Journal of midwifery & women's health·2017
Same author

Rethinking the Well Woman Visit: A Scoping Review to Identify Eight Priority Areas for Well Woman Care in the Era of the Affordable Care Act.

Women's health issues : official publication of the Jacobs Institute of Women's Health·2016
Same author

Regulation of Certified Nurse-Midwife Scope of Practice: Change in the Professional Practice Index, 2000 to 2015.

Journal of midwifery & women's health·2015
Same author

Long-acting reversible contraceptives for teenagers: primary care recommendations.

The Nurse practitioner·2015
Same author

Applying ethical practice competencies to the prevention and management of unintended pregnancy.

Journal of obstetric, gynecologic, and neonatal nursing : JOGNN·2012
Same author

Clinical issues in post-abortion care.

The Nurse practitioner·2011

Area of Science:

  • Reproductive Health
  • Pharmacology
  • Public Health

Background:

  • Mifepristone (RU-486) was approved by the US Food and Drug Administration (FDA) for medication abortion.
  • The article reviews medication abortion 6 years after mifepristone's FDA approval.
  • Epidemiologic data on abortion, access, and safety are considered.

Purpose of the Study:

  • To provide an overview of medication abortion in the United States.
  • To discuss the safety of medication abortion in comparison to aspiration abortion.
  • To present innovative protocols and discuss clinical implications.

Main Methods:

  • Review of epidemiologic data on abortion.
  • Analysis of abortion safety, including risks of medication and aspiration methods.
  • Discussion of Clostridium sordellii infections and scientific knowledge limitations.

Main Results:

  • Medication abortion adoption is examined within the context of abortion statistics and access.
  • Risks are discussed concerning abortion-related mortality and rare infections.
  • Innovative protocols and their clinical implications are presented.

Conclusions:

  • Medication abortion with mifepristone has been integrated into US reproductive healthcare.
  • Safety data and emerging protocols inform clinical practice.
  • Further research may be needed on infection incidence and long-term outcomes.

Related Experiment Videos